CLINICAL ROLE -
Overcoming the Biotech Investment Paradox
Big pharma companies have become more measured in their risk taking, with mergers and acquisitions gradually giving way to joint ventures and partnerships.
Three Keys to Implementing Artificial Intelligence in Drug Discovery
AI-based technologies are increasingly being used for things such as virtual screening, physics-based biological activity assessment, and drug crystal-structure prediction.
The Renaissance of Small Molecule Drug Discovery
Last year, the majority of new drug approvals were for small molecules, including treatments for HIV, cancer, infections, heart and kidney disease, and neurological disorders.
2 Clarke Drive Cranbury, NJ 08512